Key facts
- Notable investors include Higin Capital, Kumamoto University.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Uromics
- ·The full record, as it builds
Funding rounds
No funding rounds for Uromics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Uromics
Developer of urine testing systems designed to help protect families and communities. The company's system collects information painlessly and without the burden of visiting a doctor by simply collecting a small amount of urine at home and providing user-friendly indicators through precise analysis using LC-MS, uses everyday urine data to bring peace of mind to individuals, families, and communities, enabling users to get a simple urine test kit and track their health conditions.
- Sector
- Healthcare
- HQ
- Kumamoto, Japan
- Founded
- 2025
- Website
- uromics.jp/
- Ownership
- Privately Held (backing)
Uromics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Uromics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Uromics in its N-PORT filings yet. We sweep new filings monthly.